Skip to main content
. 2016 Jul;4(14):266. doi: 10.21037/atm.2016.05.15

Figure 2.

Figure 2

HLA-A*0201 transgenic HHD mice were vaccinated with two immunodominant HER-2/neu-derived and two immunodominant TERT-derived peptides. Seven days later TERT vaccinated mice were grafter with HLA-A*0201 expressing EL-4HHD tumor cells and HER-2/neu vaccinated mice were grafted with HLA-A*0201 and HER-2/neu expressing EL-4HHD/HER-2 tumor cells.